Trial · NCT04325828
Adverse events34
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 34
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Anaemia | Blood and lymphatic system disorders | Apalutamide + Goserelin | 4 | 31 | |
| other | Leukopenia | Blood and lymphatic system disorders | Apalutamide + Goserelin | 3 | 31 | |
| other | Lymphopenia | Blood and lymphatic system disorders | Apalutamide + Goserelin | 2 | 31 | |
| other | Hypothyroidism | Endocrine disorders | Apalutamide + Goserelin | 6 | 31 | |
| other | Constipation | Gastrointestinal disorders | Apalutamide + Goserelin | 3 | 31 | |
| other | Diarrhoea | Gastrointestinal disorders | Apalutamide + Goserelin | 2 | 31 | |
| other | Nausea | Gastrointestinal disorders | Apalutamide + Goserelin | 4 | 31 | |
| other | Stomatitis | Gastrointestinal disorders | Apalutamide + Goserelin | 2 | 31 | |
| other | Malaise | General disorders | Apalutamide + Goserelin | 5 | 31 | |
| other | Upper Respiratory Tract Infection | Infections and infestations | Apalutamide + Goserelin | 2 | 31 | |
| other | Radiation Skin Injury | Injury, poisoning and procedural complications | Apalutamide + Goserelin | 2 | 31 | |
| other | Blood Creatinine Increased | Investigations | Apalutamide + Goserelin | 2 | 31 | |
| other | Blood Thyroid Stimulating Hormone Increased | Investigations | Apalutamide + Goserelin | 3 | 31 | |
| other | Weight Decreased | Investigations | Apalutamide + Goserelin | 4 | 31 | |
| other | Decreased Appetite | Metabolism and nutrition disorders | Apalutamide + Goserelin | 2 | 31 | |
| other | Hypertriglyceridaemia | Metabolism and nutrition disorders | Apalutamide + Goserelin | 3 | 31 | |
| other | Myalgia | Musculoskeletal and connective tissue disorders | Apalutamide + Goserelin | 5 | 31 | |
| other | Cancer Pain | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | Apalutamide + Goserelin | 2 | 31 | |
| other | Dizziness | Nervous system disorders | Apalutamide + Goserelin | 2 | 31 | |
| other | Headache | Nervous system disorders | Apalutamide + Goserelin | 3 | 31 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT04325828/events